With respect to the underlying mechanisms explaining the detrimental effect of MxA expression, we speculate that high MxA expression reflects a strong autocrine activation of the interferon-α/β signaling pathway (64) that has been proven to dampen the antitumor immune response by impairing the immunogenicity of glioma cells (61). Here, MX1 is linked to central nervous system cancer.